FDA Adverse Event Injury Summary report: N

VERCISE GEVIA

MDR report key: 11408967 · Received March 4, 2021

Report

Report Number
3006630150-2021-00737
Event Type
Injury
Date Received
March 4, 2021
Date of Event
February 9, 2021
Report Date
March 3, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
NHL
UDI-DI
08714729984443
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: (B)(4), MODEL: DB-2202-45, SERIAL: (B)(4), BATCH: 5076611. PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: (B)(4), MODEL: DB-2202-45, SERIAL: (B)(4), BATCH: 7071617.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING HEADACHES. MAGNETIC RESONANCE IMAGING (MRI) AND BLOOD WORK WERE NEGATIVE FOR INFECTION, FLUID, AND ALLERGIES. THE PATIENT WAS ADMINISTERED MEDICATION. THE PATIENT OBTAINED A SECOND OPINION AND THAT PHYSICIAN SUSPECTS THAT THE PATIENT MAY HAVE A CEREBRAL SPINAL FLUID LEAK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
305636 VERCISE GEVIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION DB-1200-S 741353 08714729984443

Patients

Seq Age Sex Outcome Treatment
1 55 YR Required Intervention